FDC Limited (NSE:FDC)

Market Cap	68.74B
Revenue (ttm)	20.77B
Net Income (ttm)	2.25B
Shares Out	n/a
EPS (ttm)	13.85
PE Ratio	30.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	233,909
Average Volume	83,277
Open	426.00
Previous Close	425.15
Day's Range	406.85 - 429.20
52-Week Range	366.25 - 527.80
Beta	-0.02
RSI	57.24
Earnings Date	Feb 5, 2026

About FDC Limited

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1936
• Employees: 6,857
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: FDC

Financial Performance

In 2024, FDC Limited's revenue was 21.08 billion, an increase of 8.50% compared to the previous year's 19.43 billion. Earnings were 2.67 billion, a decrease of -12.59%.